Innovent Biologics, Inc. (IVBXF)
10.91
-0.18
(-1.59%)
USD |
OTCM |
Nov 16, 16:00
Innovent Biologics Price : 10.91 for Nov. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 10.91 | 10.91 | 10.91 | 10.91 | 547.00 |
| Nov 13, 2026 | 11.08 | 11.08 | 11.08 | 11.08 | 831.00 |
| Nov 12, 2026 | 10.89 | 11.06 | 10.89 | 11.06 | 6193.00 |
| Nov 11, 2026 | 10.96 | 11.09 | 10.76 | 11.09 | 3309.00 |
| Nov 10, 2026 | 11.19 | 11.24 | 11.19 | 11.24 | 1139.00 |
| Nov 09, 2026 | 11.00 | 11.06 | 11.00 | 11.06 | 3033.00 |
| Nov 06, 2026 | 11.00 | 11.10 | 11.00 | 11.10 | 6741.00 |
| Nov 05, 2026 | 11.39 | 11.39 | 10.56 | 11.18 | 1061.00 |
| Nov 04, 2026 | 11.31 | 11.31 | 11.31 | 11.31 | 567.00 |
| Nov 03, 2026 | 10.34 | 10.35 | 10.07 | 10.07 | 1624.00 |
| Nov 02, 2026 | 10.53 | 10.53 | 10.53 | 10.53 | 644.00 |
| Oct 30, 2026 | 11.10 | 11.10 | 9.90 | 9.90 | 3294.00 |
| Oct 29, 2026 | 9.658 | 11.30 | 9.658 | 11.30 | 636.00 |
| Oct 28, 2026 | 9.12 | 11.11 | 9.12 | 11.11 | 3255.00 |
| Oct 27, 2026 | 10.60 | 10.60 | 10.10 | 10.10 | 1247.00 |
| Oct 26, 2026 | 11.50 | 11.50 | 10.65 | 10.65 | 1620.00 |
| Oct 23, 2026 | 11.55 | 11.55 | 11.55 | 11.55 | 819.00 |
| Oct 22, 2026 | 11.60 | 11.60 | 11.60 | 11.60 | 1131.00 |
| Oct 21, 2026 | 12.21 | 12.21 | 12.21 | 12.21 | 727.00 |
| Oct 20, 2026 | 12.01 | 12.01 | 12.01 | 12.01 | 589.00 |
| Oct 19, 2026 | 12.20 | 12.20 | 12.05 | 12.20 | 14925.00 |
| Oct 16, 2026 | 12.50 | 12.50 | 12.50 | 12.50 | 590.00 |
| Oct 15, 2026 | 12.56 | 12.56 | 12.50 | 12.50 | 1305.00 |
| Oct 14, 2026 | 11.37 | 11.37 | 11.37 | 11.37 | 1304.00 |
| Oct 13, 2026 | 10.82 | 11.64 | 10.82 | 11.35 | 14255.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ascletis Pharma, Inc. | 0.625 |
| CStone Pharmaceuticals Co. Ltd. | 0.6892 |
| RemeGen Co., Ltd. | 9.96 |
| InnoCare Pharma Ltd. | 1.60 |
| Adagene, Inc. | 1.60 |
Price Related Metrics
| PE Ratio | 109.41 |
| PS Ratio | 8.568 |
| Price to Free Cash Flow | 10.52 |
| Earnings Yield | 0.91% |
| Market Cap | 18.96B |
| Operating PE Ratio | 50.72 |
| Normalized PE Ratio | 124.24 |